Study to compare efficacy and safety of topical DCF100, TIB200&SPR300

• Research type

  Research Study

• Full title

  A Randomised, Double Blind, Cross Over Clinical Study in Healthy Human Volunteers to Assess the Efficacy and Safety of Three Different Topical Analgesics (DCF100, TIB200 And SPR300) versus Placebo and Active Control(s) in a Model of UV-Induced Inflammatory Pain

• IRAS ID

  167501

• Contact name

  Annelize Koch

• Contact email

  Annelize.Koch@parexel.com

• Sponsor organisation

  Futura Medical Developments Limited

• Eudract number

  2014-004726-18

• Duration of Study in the UK

  0 years, 3 months, 9 days

• Research summary

  To assess the pharmacodynamic effect (what drugs do to the body) and safety of three topical analgesics (painkillers), DCF100, TIB200, and SPR300 compared to topical placebo and active topical reference products in a model of UV-induced inflammatory pain (pain caused by exposure to UV light [sunburn]).

• REC name

  South Central - Berkshire Research Ethics Committee

• REC reference

  15/SC/0039

• Date of REC Opinion

  2 Feb 2015

• REC opinion

  Favourable Opinion